Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-724,714 in HER2+ Metastatic Breast Cancer
NCT00102895Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Apr 2005
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of CP-724714 in breast cancer, sponsored by Pfizer. Started Apr 2005; status: terminated.
02
Drugs
CP-724714
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00102895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102895.